Skip to main content

Table 3 Antimalarial treatments for children with uncomplicated malaria presenting to health facilities with artemether-lumefantrine in stock – change of practice between 2004 and 2006 surveys in four districts in Zambia

From: Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study

2004 5–9 kg (N = 254) = 10 kg (N = 192)
  No (%) 95% CI* No (%) 95% CI*
   Artemether-lumefantrine 6 (2.4) 0, 5.7 42 (21.9) 12.4, 31.3
   Sulphadoxine-pyrimethamine 183 (72.1) 61.0, 83.1 103 (53.7) 39.7, 67.6
   Quinine 9 (3.5) 0.3, 6.8 6 (3.1) 0.4, 5.9
   No antimalarial prescribed 56 (22.1) 11.6, 32.5 41 (21.4) 12.7, 30.0
2006 5–9 kg (N = 351) ≥ 10 kg (N = 374)
  No (%) 95% CI* No (%) 95% CI*
   Artemether-lumefantrine 144 (41.0) 31.5, 50.5 219 (58.6) 50.2, 66.9
   Sulphadoxine-pyrimethamine 77 (21.9) 15.4, 28.5 51 (13.6) 7.1, 20.2
   Quinine 8 (2.3) 0.1, 4.5 14 (3.7) 0, 7.9
   No antimalarial prescribed 122 (34.8) 27.2, 42.3 90 (24.1) 17.4, 30.7
  1. * Confidence intervals adjusted for cluster sampling